慢性重型乙型肝炎是一种病情严重、治疗困难 ,且以病死率高为特征的疾病 ,一直是国内外研究的热点。为了提高存活率 ,降低病死率 ,我院于 1999年 10月开始 ,应用拉米夫定治疗慢性重型乙型肝炎 ,现将治疗结果报告如下。资料和方法一、一般资料选择我院 1999年 10月至 2 0 0 1年 Chronic severe hepatitis B is a kind of disease characterized by severe illness, difficult treatment and high mortality rate. It has always been a hot research field at home and abroad. In order to improve the survival rate and reduce the mortality, our hospital began in October 1999, the application of lamivudine treatment of chronic severe hepatitis B, the treatment results are reported as follows. Materials and methods First, the general information to choose our hospital from October 1999 to 2001